Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cymelarsan

Known as: Cymelarsen 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
ETHNOPHARMACOLOGICAL RELEVANCE Leaves from the plant species studied herein are traditionally used in northern Nigeria against… Expand
  • table 1
  • figure 1
  • table 3
  • figure 2
  • figure 3
2013
2013
Graphical abstract Highlights ► Diminazene transporter in Trypanosoma congolense has been proposed to be TcoAT1. ► Here, TcoAT1… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2010
2010
Trypanocidal sensitivity studies were conducted to assess the efficacy of Diminazene diaceturate (Diminasan) and Bis… Expand
Highly Cited
2007
Highly Cited
2007
Treatment of many infectious diseases is under threat from drug resistance. Understanding the mechanisms of resistance is as high… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
1997
1997
We have examined cross-resistance between trypanocidal drugs using a well-characterised drug-sensitive line, 247, and its… Expand
1996
1996
Abstract Continuous exposure of Trypanosoma evansi bloodstream forms to Cymelarsan in vitro resulted in the induction of… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1995
Highly Cited
1995
Following the demonstration that the transport of melaminophenyl arsenical drugs in Trypanosoma brucei is dependent upon an… Expand
1994
1994
The antitrypanosomal drug melarsamine hydrochloride (MelCy) (trade name, Cymelarsan) is a melamino-phenylarsine made by… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
1991
1991
Forty buffaloes naturally infected with Trypanosoma evansi in the South of China were treated with a single dose of a new… Expand
1990
1990
The trypanocidal activity of an arsenical compound (RM 110; mel Cy; Cymelarsan) was tested in susceptible and drug-resistant… Expand